TrialHaematologica2024

Carfilzomib, thalidomide, and dexamethasone are safe and effective in relapsed and/or refractory multiple myeloma: final report of the single-arm, multicenter, phase II ALLG MM018/AMN002 study.

Slavisa Ninkovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.